APA (7th ed.) Citation

C, R., F, R., M, L., R, C., S, V., G, M., . . . L, M. (2025). Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis. Neurology, 105(3), e213744. https://doi.org/10.1212/WNL.0000000000213744

Chicago Style (17th ed.) Citation

C, Robin, et al. "Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis." Neurology 105, no. 3 (2025): e213744. https://doi.org/10.1212/WNL.0000000000213744.

MLA (9th ed.) Citation

C, Robin, et al. "Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis." Neurology, vol. 105, no. 3, 2025, p. e213744, https://doi.org/10.1212/WNL.0000000000213744.